Anzeige
Mehr »
Login
Montag, 09.09.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Von Null auf 200 Millionen Dollar: Der unaufhaltsame Aufstieg von West Red Lake Gold
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
611 Leser
Artikel bewerten:
(2)

The Austrian Academic Library Consortium and Elsevier Agree to Pilot for Reading and Open Access Publishing

AMSTERDAM, THE NETHERLANDS / ACCESSWIRE / March 18, 2021 / Elsevier, a global leader in research publishing and information analytics, and the Kooperation E-Medien Österreich (KEMÖ) / The Austrian Academic Library Consortium, including the Austrian Science Fund (FWF), have agreed on a three-year pilot to support continued reading and open access (OA) publishing for Austrian researchers. This pilot allows OA publishing in Elsevier's hybrid journals together with an additional one-year agreement that will support Austrian researchers to publish in fully gold open access journals. This agreement complements Elsevier's transformative and pilot agreements across many European countries and represents libraries, the funder and the publisher coming together to support open access.

Elsevier will support the Austrian researcher community's ambitions, making their latest research freely available at the point of publication. Elsevier is determined to find the right solutions for our customers and meet our customers' diverse OA requirements across different academic institutions worldwide. We do so while critically ensuring published research remains trusted and of a high quality. This agreement will support over 40 Austrian institutions, helping them share their latest research globally.

The new agreement program will take effect from January 1, 2021 through to the end of 2023.

We continue to test and learn from the OA agreements that are already being put into practice with institutions and governments worldwide, which enables us to work with our partners to continually improve our OA offerings, such as building new workflows and submission processes to provide greater visibility, transparency and a best-in-class publishing experience for authors.

Brigitte Kromp, University of Vienna, Head of the Austrian Central Library for Physics and Chemistry Library and representative for Open Access in the Austrian Academic Library Consortium said: "This agreement with Elsevier represents a significant step towards our goal of making Austrian research accessible to all. An important feature of this pilot agreement is that articles in the eligible hybrid and gold open access journals are included, offering full flexibility to researchers at participating institutions. We will continue our discussions with Elsevier on including the Cell Press portfolio and other journals that are currently excluded from the agreement."

Ulrike Fenz-Kortschak, interim director of the KEMÖ Head Office, emphasizes, "that it has been possible to unite several member types represented in KEMÖ, including: public universities, private universities, universities of applied sciences, research institutes and a research funder in order to cover a big spectrum of the tertiary education sector in Austria with this read and publishing agreement."

Gino Ussi, Executive Vice President, Elsevier said: "This pilot contract with KEMÖ is a great opportunity to explore new ways to support their researchers to share their research globally, and we welcome the participation of FWF as the leading national funder in Austria. The Elsevier team is looking forward to supporting Austria's world-class researchers to access and publish credible, high quality, trusted research. In 2021, the importance of helping researchers advance science and improve health outcomes for the benefit of society has never been more critical, and we are committed to helping make Austria research available to all."

The agreement is the latest in a series of transformative agreements Elsevier has reached with customers across Europe, the US, Asia Pacific and the Middle East.

In 2020 Elsevier published nearly 81,000 gold or pay-to-publish OA articles an increase of 65 percent over 2019, making us one of the largest open access publishers in the world. Nearly all of Elsevier's 2,600 journals now enable OA publishing, including 500 fully OA journals.

Elsevier enables researchers to stay up to date with the latest science, technology, and health findings worldwide via ScienceDirect, Elsevier's leading platform of peer-reviewed scholarly literature. Overall, ScienceDirect gives researchers access to 18 million articles from over 2,600 journals published by Elsevier and our society partners.

About Elsevier
As a global leader in information and analytics, Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. We do this by facilitating insights and critical decision-making for customers across the global research and health ecosystems.

In everything we publish, we uphold the highest standards of quality and integrity. We bring that same rigor to our information analytics solutions for researchers, health professionals, institutions and funders.

Elsevier employs 8,100 people worldwide. We have supported the work of our research and health partners for more than 140 years. Growing from our roots in publishing, we offer knowledge and valuable analytics that help our users make breakthroughs and drive societal progress. Digital solutions such as ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath support strategic research management, R&D performance, clinical decision support, and health education. Researchers and healthcare professionals rely on our 2,500+ digitized journals, including The Lancet and Cell; our 40,000 eBook titles; and our iconic reference works, such as Gray's Anatomy. With the Elsevier Foundation and our external Inclusion & Diversity Advisory Board, we work in partnership with diverse stakeholders to advance inclusion and diversity in science, research and healthcare in developing countries and around the world.

Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers.

Contacts
Andrew Davis
Vice President, Elsevier Communications UK
andrew.davis@elsevier.com
www.elsevier.com

SOURCE: Elsevier



View source version on accesswire.com:
https://www.accesswire.com/636146/The-Austrian-Academic-Library-Consortium-and-Elsevier-Agree-to-Pilot-for-Reading-and-Open-Access-Publishing

© 2021 ACCESSWIRE
Drei potenzielle Vervielfacher aus Osteuropa

In unserem kostenlosen Spezialreport nehmen wir Sie mit auf eine Reise durch die dynamischen und oft unterbewerteten Aktienmärkte Osteuropas. Die Region erlebt ein beeindruckendes Wirtschaftswachstum, das weit über den Erwartungen vieler Analysten liegt. Während westliche Märkte gesättigt erscheinen, bieten osteuropäische Unternehmen einzigartige Investitionsmöglichkeiten zu attraktiven Bewertungen.

Profitieren Sie vom Wachstum Osteuropas!

In dieser Ausgabe stellen wir Ihnen drei Top-Aktien vor, die nicht nur durch solide Fundamentaldaten glänzen, sondern auch durch ein enormes Wachstumspotenzial in den kommenden Jahren. Erfahren Sie, warum diese Favoriten bereit sind, die Märkte zu erobern und wie Sie als Investor von dieser Entwicklung profitieren können.

Verpassen Sie nicht die Chance, Teil dieser aufstrebenden Wirtschaft zu sein. Fordern Sie sofort unseren brandneuen Spezialreport an und erfahren Sie, bei welchen unentdeckten Perlen noch enormes Potenzial schlummert.

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.